These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23012845)

  • 1. [Phagocytosis of Mycobacterium leprae down-regulates anti-microbial activity of murine macrophages against Mycobacterium intracellulare].
    Tatano Y; Sano C; Emori M; Saito H; Sato K; Shimizu T; Tomioka H
    Nihon Hansenbyo Gakkai Zasshi; 2012 Sep; 81(3):175-83. PubMed ID: 23012845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that coating of Mycobacterium leprae surface antigens reduces its ability to hinder host microbicidal functions.
    Rastogi N; Frehel C
    Zentralbl Bakteriol; 1990 Mar; 272(3):337-46. PubMed ID: 2184820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in T cell signal transduction by M. leprae antigens is associated with downregulation of second messengers PKC, calcium, calcineurin, MAPK and various transcription factors in leprosy patients.
    Chattree V; Khanna N; Rao DN
    Mol Immunol; 2007 Mar; 44(8):2066-77. PubMed ID: 17046060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.
    Rastogi N; Cadou S; Hellio R
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):278-91. PubMed ID: 2071985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antigenic complex that restores ability in leprosy patients to kill Mycobacterium leprae--the probable molecular events identified by in vitro experiments.
    Mahadevan PR; Robinson P
    Trop Med Parasitol; 1990 Sep; 41(3):310-3. PubMed ID: 2255852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.
    Agrewala JN; Kumar B; Vohra H
    Clin Exp Immunol; 1998 Jan; 111(1):56-63. PubMed ID: 9472661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation by protein kinase of phagocytosis of Mycobacterium leprae by macrophages.
    Prabhakaran K; Harris EB; Randhawa B
    J Med Microbiol; 2000 Apr; 49(4):339-342. PubMed ID: 10755627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N; Gelber RR; Engleman EG
    J Immunol; 1987 Jan; 138(2):570-4. PubMed ID: 2947952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of the mRNA expression by macrophages infected with Mycobacterium leprae and Mycobacterium avium complex.
    Shimizu T; Tomioka H; Matsuoka M; Sano C
    Int J Lepr Other Mycobact Dis; 2002 Dec; 70(4):250-9. PubMed ID: 12768926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
    Maw WW; Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex.
    Sano C; Sato K; Shimizu T; Kajitani H; Kawauchi H; Tomioka H
    Clin Exp Immunol; 1999 Mar; 115(3):435-42. PubMed ID: 10193415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro model for the lepromatous leprosy granuloma: fate of Mycobacterium leprae from target macrophages after interaction with normal and activated effector macrophages.
    Hagge DA; Ray NA; Krahenbuhl JL; Adams LB
    J Immunol; 2004 Jun; 172(12):7771-9. PubMed ID: 15187161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to leprosy. 1. The proliferative response of murine T lymphocytes to Mycobacterium leprae.
    Douglas-Jones AG; Watson JD
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):412-20. PubMed ID: 3900249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal by interleukin-2 of the T cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae.
    Haregewoin A; Mustafa AS; Helle I; Waters MF; Leiker DL; Godal T
    Immunol Rev; 1984 Aug; 80():77-86. PubMed ID: 6386665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.